Virtu Financial LLC Bellus Health Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$8.22 - $10.76 $87,345 - $114,335	10,626 New	10,626 $87,000
Q4 2021 Feb 17, 2022	SELL	$5.26 - $8.3 $402,200 - $634,651	-76,464 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.7 - $6.64 $147,611 - $363,015	54,671 Added 250.86%	76,464 $469,000
Q2 2021 Sep 17, 2021	BUY	$3.11 - $4.61 $6,583 - $9,759	2,117 Added 10.76%	21,793 $68,000
Q1 2021 May 19, 2021	BUY	$3.03 - $4.58 $59,618 - $90,116	19,676 New	19,676 $76,000
Q4 2020 Feb 24, 2021	SELL	$2.27 - $3.3 $38,290 - $55,664	-16,868 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.14 - $12.02 $36,097 - $202,753	16,868 New	16,868 $38,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.